Random treatment assignment using mathematical equipoise for comparative effectiveness trials
- PMID: 21348950
- PMCID: PMC3076795
- DOI: 10.1111/j.1752-8062.2010.00253.x
Random treatment assignment using mathematical equipoise for comparative effectiveness trials
Abstract
In controlled clinical trials, random assignment of treatment is appropriate only when there is equipoise, that is, no clear preference among treatment options. However, even when equipoise appears absent because prior trials show, on average, one treatment yields superior outcomes, random assignment still may be appropriate for some patients and circumstances. In such cases, enrollment into trials may be assisted by real-time patient-specific predictions of treatment outcomes, to determine whether there is equipoise to justify randomization. The percutaneous coronary intervention thrombolytic predictive instrument (PCI-TPI) computes probabilities of 30-day mortality for patients having ST elevation myocardial infarction (STEMI), if treated with thrombolytic therapy (TT), and if treated with PCI. We estimated uncertainty around differences in their respective predicted benefits using the estimated uncertainty of the model coefficients. Using the 2,781-patient PCI-TPI development dataset, we evaluated the distribution of predicted benefits for each patient. For three typical clinical situations, randomization was potentially warranted for 70%, 93%, and 80% of patients. Predictive models may allow real-time patient-specific determination of whether there is equipoise that justifies trial enrollment for a given patient. This approach may have utility for comparative effectiveness trials and for application of trial results to clinical practice.
© 2011 Wiley Periodicals, Inc.
Figures
Similar articles
-
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.Am J Cardiol. 2008 Mar 15;101(6):790-5. doi: 10.1016/j.amjcard.2007.10.050. Epub 2008 Jan 28. Am J Cardiol. 2008. PMID: 18328842 Clinical Trial.
-
Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data.Vasc Health Risk Manag. 2009;5(1):243-7. doi: 10.2147/vhrm.s4525. Epub 2009 Apr 8. Vasc Health Risk Manag. 2009. PMID: 19436647 Free PMC article.
-
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Ann Emerg Med. 2008. PMID: 19027496 Review.
-
The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention.JACC Cardiovasc Interv. 2009 Oct;2(10):925-30. doi: 10.1016/j.jcin.2009.08.009. JACC Cardiovasc Interv. 2009. PMID: 19850250
-
Developing Software to Predict Patient Responses to Knee Osteoarthritis Treatments and to Identify Patients for Possible Enrollment in Randomized Controlled Trials [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2019 Sep. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2019 Sep. PMID: 38346132 Free Books & Documents. Review.
Cited by
-
An example of medical device-based projection of clinical trial enrollment: Use of electrocardiographic data to identify candidates for a trial in acute coronary syndromes.J Clin Transl Sci. 2018 Dec;2(6):377-383. doi: 10.1017/cts.2019.365. J Clin Transl Sci. 2018. PMID: 31404280 Free PMC article.
-
The use of patient-specific equipoise to support shared decision-making for clinical care and enrollment into clinical trials.J Clin Transl Sci. 2019 Feb;3(1):27-36. doi: 10.1017/cts.2019.380. J Clin Transl Sci. 2019. PMID: 31404154 Free PMC article.
-
Efficacy and Effectiveness Too Trials: Clinical Trial Designs to Generate Evidence on Efficacy and on Effectiveness in Wide Practice.Clin Pharmacol Ther. 2019 Apr;105(4):857-866. doi: 10.1002/cpt.1347. Epub 2019 Feb 12. Clin Pharmacol Ther. 2019. PMID: 30610746 Free PMC article.
-
EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.Trans Am Clin Climatol Assoc. 2018;129:279-300. Trans Am Clin Climatol Assoc. 2018. PMID: 30166723 Free PMC article.
-
A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials.Clin Pharmacol Ther. 2014 Feb;95(2):147-53. doi: 10.1038/clpt.2013.177. Epub 2013 Sep 23. Clin Pharmacol Ther. 2014. PMID: 24060819 Free PMC article.
References
-
- Rothwell PM. Can overall results of clinical trials be applied to all patients Lancet. 1995; 345(8965): 1616–1619. - PubMed
-
- Kent DM, Hayward F. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007; 298(10): 1209–1212. - PubMed
-
- Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 2005; 365(9455): 256–265. - PubMed
-
- Kent DM, Hayward RA. When averages hide individual differences in clinical trials. Am Sci. 2007; 95: 60–68.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
